PRICE T ROWE ASSOCIATES INC /MD/ - CUE BIOPHARMA INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$39
-36.1%
16,6410.0%0.00%
Q2 2023$6116,6410.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Prosight Management, LP 1,840,510$5,245,4542.86%
P.A.W. CAPITAL CORP 180,000$513,0001.40%
Bleichroeder LP 861,278$2,454,6420.53%
Monaco Asset Management SAM 497,177$1,416,9540.43%
Slate Path Capital LP 2,402,455$6,846,9970.37%
SILVERARC CAPITAL MANAGEMENT, LLC 306,278$872,8920.25%
Robertson Stephens Wealth Management, LLC 478,500$1,363,7250.13%
CARLSON CAPITAL L P 365,000$1,040,2500.08%
Voss Capital, LLC 125,000$356,2500.07%
ADVISORY RESEARCH INC 257,225$733,0910.07%
View complete list of CUE BIOPHARMA INC shareholders